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ELECTRONIC SUPPLEMENTARY MATERIAL (e-components) 
Supplemental Table 1: Assessment of methodological quality of studies. 
 
No Study Fahrleitner, et 
al [23] 
Fahrleitner-
Pammer et al [24] 
Melamed et 
al [11] 




Liew et al 
[14] 
  Questions OS JP OS JP OS JP OS JP OS JP OS JP 
1 Does the study report clear aims? Y Y Y Y Y Y Y Y Y Y Y Y 
2 Is the study reported as a case-control observational study? Y Y Y Y N N Y Y Y Y N N 
3 Is the study setting defined (e.g. hospital based; single/multi-centre)? Y Y N N Y Y Y Y Y Y Y Y 
4 Are the cases and controls recruited/sampled from similar settings? Y Y N N N N N N Y Y N N 
5 Is the recruitment of participants conducted in a geographically defined region? Y Y N N Y Y N Y Y Y1 N Y 
6 Are the methods for recruitment /sampling detailed in the study? Y Y Y N Y Y Y Y Y Y Y Y 
7 Are inclusion and exclusion criteria detailed? Y Y Y Y Y Y Y Y Y Y Y Y 
8 Are controls appropriately matched to the cases (i.e. minimum gender and age)? Y Y Y Y N N Y N Y Y N N 
9 Are participants baseline characteristics detailed? Y Y Y Y Y Y Y Y Y Y Y Y 
10 Was the diagnosis of PAD in  patients  adequately defined (i.e. Positive diagnosis of PAD by one or 
several of the following: ABPI ˂0.9; Angiography, physician’s examination; other clinical imaging) 
Y Y Y Y Y Y Y Y Y Y Y Y 
11 Is PAD severity defined in the cases? (i.e. Based on symptoms  or  the Fontaine classification : PAD 
stage I to PAD stage IV) 
Y Y Y Y N N Y Y N N N N 
12 Is PAD excluded in the controls? (Controls should be defined based on negative diagnosis of PAD (i.e. 
By ABPI (>0.9; Angiography, physician’s examination; other clinical imaging.)    
Y Y Y Y Y Y Y Y Y Y Y Y 
13 Was the assessment of vitamin D one of the main study aims? Y Y Y Y Y Y Y Y Y Y Y Y 
14 Does the study report on the total circulating 25(OH)D (i.e. the study did not report one vitamin  D 
metabolite. (i.e. 25(OH)D2 and 25(OH)D3)? 
N N Y Y Y Y Y Y Y Y Y Y 
15 Does the study detail the assay method used for assessment of 25(OH)D (e.g. radioimmunoassay (RIA),  
enzyme-linked immuno-sorbent assay (ELISA), Chemiluminescence immuno-assay (CLIA) 
Y Y Y Y Y Y Y Y Y Y Y Y 
16 Does the study detail the protocol used for vitamin D measurement (incl. blood collection and blood 
medium used; e.g. plasma, serum, whole blood)?  
Y Y Y Y Y Y Y Y N N Y Y 
17 Did the study control for seasonal variations on circulating 25(OH)D concentration? (i.e. same season or 
average across seasons)?  
Y Y Y Y N N Y Y Y Y N N 
18 Did the study report on the quality of 25(OH)D assay results? (e.g. assay precision, interassay 
reproducibility) 
Y Y N N Y Y N N Y Y N N 
19 Did the study exclude, match or adjust for cardiovascular diseases (CVD) confounders using one or 
several of statistical methods (e.g. logistic regression): Age? Gender? Body mass index (BMI)? 
Hypertension? Smoking status? Diabetes? (List)  
N N N N Y Y Y Y Y Y Y Y 
20 Does the study report findings in relation to the original aims? Y Y Y Y Y Y Y Y Y Y Y Y 
21 Does the study report findings in the context of the existing literature? Y Y Y Y Y Y Y Y Y Y Y Y 
Individual score (Y) 19 19 16 15 16 16 18 18 19 19 14 15 
Concentrations of agreement (%) 100 95.2 100 100 100 95.2 
Averaged score (%) 90.5 73.8 76.2 85.7 90.5 69.0 
 
Quality assessment questions were developed specifically to relate the quality tool to vitamin D and PAD research. The initial quality agreement 
between assessors (SO and JP) ranged from 90.5% to 95%. After a consensus meeting involving VN, MF, OS and JP, 5 out of 10 questions were 
revised and the agreement score was altered to within a range of 95.2% to 100%. Studies that scored ˂50%, 50 to 75% and ˃ 75% in the average 
score were considered to be of low, moderate, and high quality, respectively. Abbreviations: 25(OH)D: 25-hydroxyvitamin D; ABPI: arterial 
blood pressure index; JP: Jenna Pinchbeck; MF: Malindu Fernando; N: No; PAD: peripheral arterial diseases; SO: Safraz Omer; VN: Vianne 
Nsengiyumva; Y: Yes. 
